News
Vaping-linked lung injuries near 1,500
October 17, 2019
Seventy percent of patients are male, and 79% are under age 35 years.
News
FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients
October 15, 2019
The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.
News
No clear benefit from conservative oxygen in mechanical ventilation
October 14, 2019
Using conservative oxygen therapy in adults undergoing mechanical ventilation in the ICU does not increase ventilation-free days.
News
CDC updates guidance on vaping-associated lung injury
October 11, 2019
“We are not seeing a drop in cases” but a continuation of the trend of hospitalization and deaths that started in August 2019.
News
Influenza vaccination modestly reduces risk of hospitalizations in patients with COPD
October 9, 2019
Older patients with COPD need more effective influenza vaccines and other preventive strategies.
News
Histologic analysis of vaping-associated lung injury suggests chemical pneumonitis
October 4, 2019
Foamy macrophages and pneumocyte vacuolization were seen in all cases.
News
Vaping-associated lung injury cases exceed 1,000
October 3, 2019
As of Oct. 1, there have been 1,080 confirmed and probable cases of lung injury associated with the use of e-cigarettes, or vaping.
News
Lefamulin found noninferior to moxifloxacin for bacterial pneumonia
October 1, 2019
Oral lefamulin, the first pleuromutilin antibiotic approved for intravenous and oral administration, was noninferior to oral moxifloxacin for inducing an early clinical response in patients with bacterial pneumonia, acording to data from a global multicenter study of 738 individuals.
News
Vitamin C infusion falls short for sepsis and ARDS patients
October 1, 2019
Vitamin C failed to improve organ dysfunction, inflammation, or vascular injury in adults with sepsis and ARDS.
News
Caution with IVC filters in elderly
September 30, 2019
Are inferior vena cava (IVC) filters in older adults safe for prevention of subsequent pulmonary embolism (PE)?